Functional differences between M cells and enterocytes in sampling luminal antigens
| File | Size | Format | |
|---|---|---|---|
| 55354_1.pdf | 772Kb | Adobe PDF | View |
| Title | Functional differences between M cells and enterocytes in sampling luminal antigens |
|---|---|
| Author | Kyd, Jennelle M.; Cripps, Allan W |
| Journal Name | Vaccine |
| Editor | Dr. R E Spier |
| Year Published | 2008 |
| Place of publication | United Kingdom |
| Publisher | Elsevier Ltd. |
| Abstract | Oral delivery of agents such as vaccines offers a number of significant advantages over parenteral routes, yet only a small number of oral vaccines are routinely available today. The small intestine contains lymphoid aggregates that are overlaid by M cells. These aggregates are part of the gut-associated lymphoid tissues and are important for determining host responses to particulate antigenic material within the small intestine. Differentiating the receptor requirements for M cell uptake and transcytosis of bacterial antigen from the intestine has progressed although the specific signalling mechanisms that initiate antigen uptake and specifically target antigen to these cells is still relatively unknown. Microbial pathogen-associated molecular patterns (PAMPs) are recognised by the innate immune system through pattern recognition receptors (PRRs) either through direct receptor-bacterial ligand or endogenous adaptor-bacterial molecule interactions. PRRs on the surface of M cells that have been identified as important in antigen transcytosis include toll-like receptor-4, platelet-activating factor receptor and α5β1 integrin. A number of these PRRs are also found on neighbouring enterocytes and therefore the pathways signalled by receptor-ligand binding may differentially trigger different transduction pathways. Elucidation of these signalling pathways may assist in the design of effective oral vaccines that target the gut-associated lymphoid tissue. |
| Peer Reviewed | Yes |
| Published | Yes |
| Alternative URI | http://dx.doi.org/10.1016/j.vaccine.2008.09.061 |
| Copyright Statement | Copyright 2008 Elsevier. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. |
| Volume | 26 |
| Issue Number | 49 |
| Page from | 6221 |
| Page to | 6224 |
| ISSN | 0264-410X |
| Date Accessioned | 2009-04-29 |
| Date Available | 2011-10-10T06:15:24Z |
| Language | en_AU |
| Research Centre | Griffith Health Institute; Molecular Basis of Disease |
| Faculty | Griffith Health Faculty |
| Subject | Immunology |
| URI | http://hdl.handle.net/10072/23279 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1 |
Please use this identifier to cite this record: http://hdl.handle.net/10072/23279
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top